Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
Metrics: PDF 750 views | ?
1 Fondazione Italiana Fegato, AREA Science Park Basovizza, Trieste, Italy
2 Faculty of Medicine, Hasanuddin University, Makassar, Indonesia
Published: February 26, 2018
This article has been corrected: The updated Acknowledgments information is provided below:
RBL is supported by fellowships from the Lembaga Pengelola Dana Pendidikan (LPDP) of the Indonesian Ministry of Monetary, DP by NECTE project of PAR-FSC_2007-13 decree n° 3984/LAVFOR.ISTR/2014 Friuli Venezia Giulia, CHCS fellowship was partially supported by grant NIH U01AA020821. This work was supported by in-house grant from the Fondazione Italiana Fegato, Trieste, Italy, and the Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
Original article: Oncotarget. 2018; 9:2951-2961. DOI: https://doi.org/10.18632/oncotarget.23359.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.